{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:55:38Z","timestamp":1765374938720,"version":"3.46.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dialogues in Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dialog.2025.100256","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T07:52:37Z","timestamp":1762588357000},"page":"100256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cStories like ours continue\u201d: A phenomenological exploration of the lived experiences of ex-serial clinical trial volunteers in South India"],"prefix":"10.1016","volume":"7","author":[{"given":"Irene","family":"Sambath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpana B.","family":"Kosalram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"U. S. Food & Drug Administration (FDA)","key":"10.1016\/j.dialog.2025.100256_bb0005"},{"author":"World Medical Association WMA","key":"10.1016\/j.dialog.2025.100256_bb0010"},{"year":"2016","series-title":"International ethical guidelines for health-related research involving humans","author":"Council for International Organizations of Medical Sciences (CIOMS)","key":"10.1016\/j.dialog.2025.100256_bb0015"},{"key":"10.1016\/j.dialog.2025.100256_bb0020","first-page":"67","article-title":"Experimental values - Indian clinical trials and surplus health","author":"Rajan","year":"2007","journal-title":"New Left Rev"},{"key":"10.1016\/j.dialog.2025.100256_bb0025","series-title":"Modernization, and Robust Data Collection Define India as a Potential Clinical Trial Hub","article-title":"Spotlight on India: regulatory enhancements","author":"Biorasi","year":"2024"},{"year":"2015","series-title":"Clinical Trials in India: A Systematic Review","author":"Mondal","key":"10.1016\/j.dialog.2025.100256_bb0030"},{"key":"10.1016\/j.dialog.2025.100256_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.socscimed.2014.11.052","article-title":"Big-pharmaceuticalisation: clinical trials and contract research organisations in India","volume":"131","author":"Sariola","year":"2015","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.dialog.2025.100256_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cll.2012.04.008","article-title":"Clinical trials and contract research organizations in India","volume":"32","author":"Mukherjee","year":"2012","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.dialog.2025.100256_bb0045","first-page":"22","article-title":"Bioavailability and bioequivalence studies in India: a generic overview","volume":"16","author":"Rajeshwari","year":"2021","journal-title":"J Int Res Med Pharm Sci"},{"key":"10.1016\/j.dialog.2025.100256_bb0050","first-page":"228","article-title":"Ethical issues in recruitment of \u201chealthy volunteers\u201d: study of a clinical research organisation in Hyderabad. Indian","volume":"XI","author":"Krishna","year":"2014","journal-title":"J Med Ethics"},{"key":"10.1016\/j.dialog.2025.100256_bb0055","doi-asserted-by":"crossref","first-page":"1h","DOI":"10.1162\/152651601300169220","article-title":"Maybe we should pay them more","author":"Zink","year":"2001","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.dialog.2025.100256_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0190272516657655","article-title":"Risk and emotion among healthy volunteers in clinical trials","volume":"79","author":"Cottingham","year":"2016","journal-title":"Soc Psychol Q"},{"key":"10.1016\/j.dialog.2025.100256_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/03085147.2015.1113703","article-title":"\u2018I\u2019m still a hustler\u2019: entrepreneurial responses to precarity by participants in phase I clinical trials","volume":"44","author":"Monahan","year":"2015","journal-title":"Econ Soc"},{"key":"10.1016\/j.dialog.2025.100256_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1353\/pbm.2003.0094","article-title":"Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials?","volume":"46","author":"Tishler","year":"2003","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.dialog.2025.100256_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112670","article-title":"\u2018Becoming-with\u2019 a repeat healthy volunteer: managing and negotiating trust among repeat healthy volunteers in commercial clinical drug trials","volume":"245","author":"Mwale","year":"2020","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.dialog.2025.100256_bb0080","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18203\/2394-6040.ijcmph20211983","article-title":"Clinical trials on healthy volunteers in Mumbai and Ahmedabad: expanding the framework of expropriation","volume":"8","author":"Wadkar","year":"2021","journal-title":"Int J Community Med Public Heal"},{"key":"10.1016\/j.dialog.2025.100256_bb0085","first-page":"356","article-title":"Post an unforeseen outcome of serial volunteering in clinical trials, what does the affected community want?","volume":"11","author":"Sambath","year":"2020","journal-title":"Indian J Public Heal Res Dev"},{"key":"10.1016\/j.dialog.2025.100256_bb0090","doi-asserted-by":"crossref","DOI":"10.4103\/2229-3485.103593","article-title":"Public awareness of clinical trials\u00a0: a qualitative pilot study in Pune","author":"Joshi","year":"2012","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.dialog.2025.100256_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0068666","article-title":"PARTAKE survey of public knowledge and perceptions of clinical research in India","volume":"8","author":"Burt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dialog.2025.100256_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/jphi.JPHI_31_17","article-title":"Compensation to clinical trial participants in India\u00a0: a gap analysis","volume":"7","author":"Urooj","year":"2017","journal-title":"Int J Pharm Investig"},{"key":"10.1016\/j.dialog.2025.100256_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010730","article-title":"What leads Indians to participate in clinical trials\u00a0? A meta-analysis of qualitative studies","author":"Shah","year":"2010","journal-title":"PLoS One"},{"year":"2010","series-title":"The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects","author":"Abadie","key":"10.1016\/j.dialog.2025.100256_bb0110"},{"year":"2017","series-title":"Healthy volunteers in commercial clinical drug trials: When human beings become Guinea pigs","author":"Mwale","key":"10.1016\/j.dialog.2025.100256_bb0115"},{"key":"10.1016\/j.dialog.2025.100256_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024224","article-title":"Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials","volume":"9","author":"Manton","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.dialog.2025.100256_bb0125","article-title":"Lured by blood money: Serial volunteers set a disturbing trend","author":"Pulla","year":"2017","journal-title":"The Hindu"},{"year":"2009","series-title":"Interpretative phenomenological analysis: theory, method and research","author":"Smith","key":"10.1016\/j.dialog.2025.100256_bb0130"},{"key":"10.1016\/j.dialog.2025.100256_bb0135","first-page":"361","article-title":"A practical guide to using interpretative phenomenological analysis in qualitative research psychology","volume":"18","author":"Pietkiewicz","year":"2012","journal-title":"Czas Psychol"},{"key":"10.1016\/j.dialog.2025.100256_bb0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1468794119884806","article-title":"Conducting in-depth interviews with and without voice recorders: a comparative analysis","volume":"20","author":"Rutakumwa","year":"2020","journal-title":"Qual Res"},{"key":"10.1016\/j.dialog.2025.100256_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"year":"1985","series-title":"Naturalistic Inquiry","author":"Lincoln","key":"10.1016\/j.dialog.2025.100256_bb0150"},{"key":"10.1016\/j.dialog.2025.100256_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10433-010-0168-y","article-title":"Language differences in qualitative research: is meaning lost in translation?","volume":"7","author":"van Nes","year":"2010","journal-title":"Eur J Ageing"},{"key":"10.1016\/j.dialog.2025.100256_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1468794104044430","article-title":"Qualitative research and translation dilemmas","volume":"4","author":"Temple","year":"2004","journal-title":"Qual Res"},{"key":"10.1016\/j.dialog.2025.100256_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/medethics-2012-100755","article-title":"Evaluation of factors that motivate participants to consent for non-therapeutic trials in India","volume":"39","author":"Doshi","year":"2013","journal-title":"J Med Ethics"},{"year":"2014","series-title":"Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy","author":"Cooper","key":"10.1016\/j.dialog.2025.100256_bb0170"},{"key":"10.1016\/j.dialog.2025.100256_bb0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0950017019885069","article-title":"Sacrificial labour: social inequality, identity work, and the damaging pursuit of elusive futures","volume":"34","author":"Monahan","year":"2020","journal-title":"Work Employ Soc"},{"year":"2020","series-title":"Adverse Events","author":"Fisher","key":"10.1016\/j.dialog.2025.100256_bb0180"},{"year":"2005","series-title":"Burden of disease in the India","key":"10.1016\/j.dialog.2025.100256_bb0185"},{"key":"10.1016\/j.dialog.2025.100256_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1740774519877851","article-title":"Informal professionalization of healthy participants in phase I clinical trials in Russia","volume":"16","author":"Olga","year":"2019","journal-title":"Clin Trials"},{"key":"10.1016\/j.dialog.2025.100256_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1740774515602868","article-title":"Risks of phase I research with healthy participants: a systematic review","volume":"13","author":"Johnson","year":"2017","journal-title":"Clin Trials"},{"key":"10.1016\/j.dialog.2025.100256_bb0200","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41591-023-02490-6","article-title":"The VolREthics initiative to protect the well-being of healthy volunteers in biomedical research","volume":"29","author":"Bompart","year":"2023","journal-title":"Nat Med"},{"issue":"41","key":"10.1016\/j.dialog.2025.100256_bb0205","first-page":"829","article-title":"Subversive subjects: rule-breaking and deception in clinical trials","volume":"38","author":"Dresser","year":"2013","journal-title":"J Law Med"},{"key":"10.1016\/j.dialog.2025.100256_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1556264614568280","article-title":"Using \u201cclinical trial diaries\u201d to track patterns of participation for serial healthy volunteers in U.S. phase I studies","volume":"10","author":"Edelblute","year":"2015","journal-title":"J Empir Res Hum Res Ethics"},{"key":"10.1016\/j.dialog.2025.100256_bb0215","series-title":"Recalibrating Stigma","first-page":"1","article-title":"Introduction: Recalibrating stigma","author":"Thomas","year":"2025"},{"key":"10.1016\/j.dialog.2025.100256_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/S0963180118000476","article-title":"Healthy volunteers for clinical trials in resource-poor settings: National Registries can Address Ethical and safety concerns","volume":"28","author":"Bompart","year":"2019","journal-title":"Camb Q Healthc Ethics"},{"key":"10.1016\/j.dialog.2025.100256_bb0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/15265161.2012.719267","article-title":"The elephant in the (board) room: the role of contract research organizations in international clinical research","volume":"12","author":"Foster","year":"2012","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.dialog.2025.100256_bb0230","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00228-012-1231-8","article-title":"TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials","volume":"68","author":"Boyce","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"year":"2024","series-title":"Guidance for best practice for clinical trials","key":"10.1016\/j.dialog.2025.100256_bb0235"},{"year":"2025","series-title":"Global action plan for clinical trial ecosystem strengthening","key":"10.1016\/j.dialog.2025.100256_bb0240"},{"author":"World Health Organization Sustainable Development Goals (SDG)","key":"10.1016\/j.dialog.2025.100256_bb0245"}],"container-title":["Dialogues in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277265332500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277265332500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:11:28Z","timestamp":1765372288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277265332500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S277265332500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.dialog.2025.100256","relation":{},"ISSN":["2772-6533"],"issn-type":[{"type":"print","value":"2772-6533"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cStories like ours continue\u201d: A phenomenological exploration of the lived experiences of ex-serial clinical trial volunteers in South India","name":"articletitle","label":"Article Title"},{"value":"Dialogues in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dialog.2025.100256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. CC BY 4.0","name":"copyright","label":"Copyright"}],"article-number":"100256"}}